Company Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,959 18,782 13,803 7,625 7,383 6,757 - -
Change - -18.19% -26.51% -44.76% -3.16% -8.48% - -
Enterprise Value (EV) 1 21,903 16,608 11,574 5,707 6,451 5,418 5,127 4,629
Change - -24.17% -30.31% -50.69% 13.04% -16.02% -5.36% -9.72%
P/E 24.7x 18.6x 25.2x 67.6x 28.1x 12.6x 10.6x 8.92x
PBR 3.49x 2.53x 1.78x 1.02x 1.03x 0.9x 0.86x 0.82x
PEG - 2.14x -0.6x -0.9x 0x 0x 0.6x 0.5x
Capitalization / Revenue 1.57x 1.08x 0.79x 0.42x 0.43x 0.37x 0.35x 0.33x
EV / Revenue 1.5x 0.95x 0.67x 0.32x 0.37x 0.3x 0.27x 0.23x
EV / EBITDA 16.9x 11x 10.6x 3.13x 9x 2.93x 2.45x 1.95x
EV / EBIT 20.5x 13.4x 11.8x 20.5x 15.3x 6.03x 4.9x 3.79x
EV / FCF - - 6.14x 3.89x 4.76x 3.72x 2.62x 1.95x
FCF Yield - - 16.3% 25.7% 21% 26.9% 38.1% 51.3%
Dividend per Share 2 0.3 0.4 0.4 0.3 0.2 0.474 0.5339 0.6487
Rate of return 0.78% 1.27% 1.73% 2.3% 1.56% 4.03% 4.54% 5.51%
EPS 2 1.561 1.697 0.9206 0.1927 0.4571 0.934 1.112 1.32
Distribution rate 19.2% 23.6% 43.4% 156% 43.8% 50.8% 48% 49.1%
Net sales 1 14,585 17,432 17,380 18,000 17,336 18,047 19,158 20,564
EBITDA 1 1,295 1,511 1,087 1,823 716.6 1,851 2,090 2,373
EBIT 1 1,066 1,243 982.9 278 422.4 897.9 1,046 1,223
Net income 1 921.5 1,010 549.4 114.1 263.4 545.1 649.7 779
Net Debt 1 -1,056 -2,174 -2,229 -1,917 -932 -1,340 -1,630 -2,128
Reference price 2 38.51 31.51 23.16 13.02 12.86 11.77 11.77 11.77
Nbr of stocks (in thousands) 596,181 596,071 596,005 585,604 574,128 574,128 - -
Announcement Date 14/03/22 17/03/23 19/03/24 27/04/25 28/04/26 - - -
1CNY in Million2CNY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
12.24x0.29x2.82x4.15% 976M
17.06x0.7x10.4x-.--% 15.19B
20.94x0.8x13.44x1.07% 6.48B
16.71x0.75x7.83x2.23% 6.38B
14.77x0.97x6.97x2.85% 4.26B
14.58x1.25x7.65x5.51% 3.25B
13.32x0.54x4.32x5.19% 2.94B
13.83x0.83x6.24x4.64% 2.93B
30.71x - - - 2.39B
Average 17.13x 0.77x 7.46x 3.2% 4.98B
Weighted average by Cap. 17.34x 0.78x 9.04x 1.98%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 002727 Stock
  4. Valuation Yixintang Pharmaceutical Group Co., Ltd.